Sonnet BioTherapeutics Holdings Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sonnet BioTherapeutics Holdings

Access the complete profile.

Sonnet BioTherapeutics Holdings Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	100 Overlook Cetner Suite 102 Princeton, NJ 08540

Sonnet BioTherapeutics Holdings's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sonnet BioTherapeutics Holdings's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Sonnet BioTherapeutics Holdings is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sonnet BioTherapeutics Holdings is a publicly traded company on using the ticker symbol HOTRW. Detailed information on company financials and operating reports can be found here: : HOTRW

Sonnet BioTherapeutics Holdings Annual Revenue and Growth Rate

Sonnet BioTherapeutics Holdings	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sonnet BioTherapeutics Holdings's revenues are gauged from an analysis of company filings.

Investor Activity

Sonnet BioTherapeutics Holdings has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
July 17, 2023	1	100%	$2 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Sonnet BioTherapeutics Holdings is developing and marketing. Sonnet BioTherapeutics Holdings doesn't have any recent trademark applications, indicating Sonnet BioTherapeutics Holdings is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRIDENT Research and development in the fields of pharmaceuticals, drug discovery, biotherapies, and biologics; research and development of new products for others in the fields of pharmaceuticals, drug discovery, biotherapies, and biologics; developing treatments for diseases by providing technology platforms in the field of biotherapeutics	10/11/2016

See all trademarks and details in the Full Report.

Market Share of Sonnet BioTherapeutics Holdings's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sonnet BioTherapeutics Holdings, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sonnet BioTherapeutics Holdings. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVO NORDISK PHARMA	Plainsboro, NJ	100
SUN PHARMACEUTICAL INDUSTRIES	Princeton, NJ	21
GENMAB US	Plainsboro, NJ	12
KYOWA KIRIN	Princeton, NJ	10
ACTELION PHARMACEUTICALS US	Titusville, NJ	2
E R SQUIBB & SONS	Princeton, NJ	2

Future Competition: Sonnet BioTherapeutics Holdings's Fastest Growing Competitors

These companies are in the same general field as Sonnet BioTherapeutics Holdings and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)